Drug intelligence / Profile preview

BTHE + Huperzine A

Development stage
Unknown
Lead developer
Wanbangde Pharmaceutical
Modality
Small Molecules
Administration
Oral
01

Overview

**BTHE + Huperzine A** appears to be a combination formula, with one component being **Huperzine A**. Huperzine A is a natural Lycopodium alkaloid isolated from Huperzia serrata and related species. It acts as a reversible acetylcholinesterase inhibitor, thereby increasing the levels of acetylcholine in the brain and is also a noncompetitive antagonist of the NMDA receptor. These actions are thought to contribute to its putative cognitive-enhancing effects and its use in traditional medicine and as a nootropic supplement for memory and concentration enhancement. Huperzine A is approved for use in China for Alzheimer's disease but is sold as a dietary supplement in other regions[1][5]. There is insufficient information available from the search results to determine what "BTHE" refers to specifically; it may be another herbal or supplemental ingredient or a brand-specific formulation.

02

Targets

NMDAR (Glutamate receptor ionotropic, NMDA)Acetylcholinesterase

Beyond the preview

Go deeper on BTHE + Huperzine A.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on BTHE + Huperzine A.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call